Antimicrobial resistance (AMR) is a major concern that keeps expanding its field of influence not only in hospitals but also for topical formulations in dermal care, cosmetics, and the pharmaceutical industry. Topical products in the form of creams, gels, ointments, and lotions are the common sources of microbial contamination, and they may rightly cause resistance if the microbial control is insufficient.
Good control of AMR in topical products depends very much on stringent antimicrobial efficacy testing, strong antimicrobial preservative effectiveness test protocols, and quality assurance over the product lifecycle. This article outlines how the manufacturers and the testing labs can be on top of the AMR challenge.
Products for topical application, in the event they are infected with bacteria, fungi, or other microorganisms, can become a source of health risks for users and lose their performance. In the case of contamination being allowed to continue or using sub-lethal levels of preservatives, this may lead to the development of resistant microbial populations that, in turn, cause antimicrobial resistance. Some of the main risks are:
Topical formulations, as a microbiological risk environment, should be handled by manufacturers who implement control measures along with thorough testing. This is the way to ensure that preservatives retain their effectiveness and that the product does not become a carrier of resistant microbes.
Just to mention, the core of dealing with antimicrobial resistance in topical products is through antimicrobial efficacy testing (which is also known as antimicrobial effectiveness and preservative efficacy testing). The main goal of these tests is to evaluate whether a composition (or a preservative system) can completely stop or merely limit the growth of microbes in certain conditions of challenge. The general idea of the process would be:
When it comes to topical products, it is quite common to see the test referred to as “challenge test” or “preservative efficacy test”. To illustrate, the lab might perform the addition of Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, and Aspergillus brasiliensis into the sample and then check the log-reduction levels at the time intervals specified.
In general, these are the antimicrobial efficacy test methods or laboratory procedures for antimicrobial efficacy testing. Labs like Eurofins CRL Research Labs offer such services.
Here are the main actions manufacturers and testing labs should take:
1. Define the microbial challenge and scope
First, they should select microorganisms that are relevant to the study (Gram-positive, Gram-negative, yeast, and mold). Next, they should establish the stressful conditions (temperature, storage, and usage simulation). This corresponds to an antimicrobial preservative efficacy test US requirement, or any other regional standard.
2. Develop the antimicrobial efficacy test protocol
The protocol must define the size of the inoculum, contact time, sampling intervals (e.g., 7 days, 14 days, 28 days), and the tested formulation (also the open/closed state). Generally, the creation of the protocol is connected with an antimicrobial efficacy test PPT (presentation) requirement or some internal documentation in a lab or regulatory submission.
3. Execute testing in an accredited lab
Choose a laboratory such as Eurofins that is recognized and follows rigorously validated methods, thus traceability is ensured. Their microbiology services include challenge tests and preservative efficacy for cosmetics and topical care.
4. Evaluate results and verify log-reduction acceptance
Typical acceptance criteria can refer, for example, to a >3 log reduction in bacteria within 7 days and no recovery or <1 log increase for the rest of the test period. If such results fail, you must return to the drawing board with the preservative system, formulation, packaging, or usage instructions.
5. Monitor ongoing product performance
You have to watch out for a change in the preservative system, the condition of the user-opened shelf, and the possible microbial adaptations even after the initial testing. This is the reason why continuous or periodic antimicrobial efficacy testing AET might be considered necessary.
6. Document and link to regulatory/compliance needs
Manufacturers of topical products have to be able to produce the records that show that they have done adequate testing, taken into account the AMR risks, and validated the preservative systems. Internal links to the testing lab scope, the protocols, and the certificates contribute to building trust.
Choosing a knowledgeable partner gives you the following benefits:
When AMR is rising globally, such assurance becomes a competitive differentiator — offering customers safety and regulatory peace of mind.
Here are comprehensive steps to follow:
What is the difference between "antimicrobial efficacy test" and "antimicrobial preservative efficacy test"?
The phrase antimicrobial efficacy test indicates the principal idea of assessment that a product can either inhibit or kill microbes. A preservative efficacy test is just a step further, in other words, evaluating how well the preservative system stays in the formulation over time and under stress conditions.
How does one control AMR risk when formulating a topical product?
Selecting a broad-spectrum preservative is the starting point. Performing a rigorous challenge/efficacy test, using protective packaging, educating, and monitoring post-market performance are all ways to achieve this objective. The routine practice in the form of an antimicrobial efficacy test method with periodic re-checking is strong evidence of the proactive control program.
Which laboratory tests should we perform to comply with regulatory expectations?
At a bare minimum, an antimicrobial efficacy testing protocol (challenge test) is necessary as an initial step and should comprise bacteria, yeast, and mold; user-simulated conditions; open and unopened packaging; and stability testing. A collaboration with a lab such as Eurofins CRL gives one easy access to the standardized test methods and validated data.
How often should we retest the preservative system for effectiveness?
There are several factors, such as the complexity of the formulation, the consumer's environment, and the risk assessment, that determine how often a retest has to be done. In many cases, companies schedule a retest that coincides with major stability milestones (e.g., 6 months, 12 months) or when there is a change in packaging, preservatives, or raw materials. In general, periodic antimicrobial effectiveness and preservative efficacy testing can serve as a source of early indication of control drift.
What happens if my topical product fails the antimicrobial test?
A failure shows that microbial growth was not adequately controlled under test conditions. This leads to the process called root-cause analysis: looking again at preservative concentration, formulation compatibility, package design, or user-interaction risk. After that, you should surely conduct a retest once changes have been implemented.
The emergence of antimicrobial resistance in topical products is not only a scientific challenge, but also a quality/regulatory requirement. The use of systematic antimicrobial efficacy testing, the implementation of robust antimicrobial preservative efficacy test protocols, and the adoption of expert services (e.g., Eurofins CRL) help in the validation of the preservative system by the formulators, documentation of performance, minimization of microbial risk, and, therefore, the creation of safer and more reliable products.
Suppose you require top microbiology and challenge-test services that are specially designed for topical, cosmetic, and personal-care applications. In that case, the first thing you need to do is to have a look at the facility provided by Eurofins CRL Microbiology Services.